Pharmerica Corporation Raises FY2014 EPS Guidance from $1.47-1.52 to $1.58-1.62 vs $1.52 Est; Raises FY2014 Sales Guidance from $1.73B-1.78B to $1.76B-1.80B vs $1.77B Est, Adj. EBITDA Raised to $123.2-126M
Paul Quintaro